Literature DB >> 9615285

Local administration of serotonin agonists blocks light-induced phase advances of the circadian activity rhythm in the hamster.

E T Weber1, R L Gannon, M A Rea.   

Abstract

Circadian rhythms in mammals are synchronized to environmental light-dark cycles through a direct retinal projection to the suprachiasmatic nucleus (SCN), a circadian clock. This process is thought to be modulated by other afferents to the SCN, including a dense serotonergic projection from the midbrain raphe. Previous work from this laboratory demonstrated that a systemically administered 5-hydroxytryptamine1A/7 (5-HT1A/7) agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) dose dependently attenuates light-induced phase shifts of the circadian activity rhythm of the Syrian hamster. In this study, we demonstrate that local injections (1-100 microM) of the 5-HT1A/7 agonists 8-OH-DPAT or 5-carboxamidotryptamine into the region of the SCN inhibit light-induced phase advances of the circadian wheel-running rhythm. In addition, the inhibitory effects of systemically administered 8-OH-DPAT were unaffected by either radiofrequency-induced lesions of the intergeniculate leaflet or 5,7-dihydroxytryptamine-induced lesions of serotonergic projections to the SCN. These findings support a modulatory role of serotonin in photic regulation of circadian phase through an action at the level of the SCN.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9615285     DOI: 10.1177/074873098129000057

Source DB:  PubMed          Journal:  J Biol Rhythms        ISSN: 0748-7304            Impact factor:   3.182


  16 in total

1.  The neuropeptide Y Y5 receptor mediates the blockade of "photic-like" NMDA-induced phase shifts in the golden hamster.

Authors:  P C Yannielli; M E Harrington
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

2.  Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.

Authors:  Robert L Gannon; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2007-08-13       Impact factor: 4.530

3.  The SSRI citalopram increases the sensitivity of the human circadian system to light in an acute dose.

Authors:  E M McGlashan; L S Nandam; P Vidafar; D R Mansfield; S M W Rajaratnam; S W Cain
Journal:  Psychopharmacology (Berl)       Date:  2018-09-15       Impact factor: 4.530

4.  Temporal changes of light-induced proteins in the SCN following treatment with the serotonin mixed agonist/antagonist BMY7378.

Authors:  Victoria M Smith; Ryan T Jeffers; Claire Wu; Jhenkruthi Vijaya Shankara; Michael C Antle
Journal:  Exp Brain Res       Date:  2015-06-06       Impact factor: 1.972

Review 5.  Endocannabinoid signalling: has it got rhythm?

Authors:  Linda K Vaughn; Gerene Denning; Kara L Stuhr; Harriet de Wit; Matthew N Hill; Cecilia J Hillard
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

6.  Inhibitory action of brotizolam on circadian and light-induced per1 and per2 expression in the hamster suprachiasmatic nucleus.

Authors:  S I Yokota; K Horikawa; M Akiyama; T Moriya; S Ebihara; G Komuro; T Ohta; S Shibata
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

7.  Glutamate blocks serotonergic phase advances of the mammalian circadian pacemaker through AMPA and NMDA receptors.

Authors:  R A Prosser
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

8.  Neurochemically and Hodologically Distinct Ascending VGLUT3 versus Serotonin Subsystems Comprise the r2-Pet1 Median Raphe.

Authors:  Rebecca A Senft; Morgan E Freret; Nikita Sturrock; Susan M Dymecki
Journal:  J Neurosci       Date:  2021-02-05       Impact factor: 6.167

9.  Site-specific effects of gastrin-releasing peptide in the suprachiasmatic nucleus.

Authors:  George J Kallingal; Eric M Mintz
Journal:  Eur J Neurosci       Date:  2013-10-28       Impact factor: 3.386

10.  Developmental alcohol exposure alters light-induced phase shifts of the circadian activity rhythm in rats.

Authors:  Yuhua Z Farnell; James R West; Wei-Jung A Chen; Gregg C Allen; David J Earnest
Journal:  Alcohol Clin Exp Res       Date:  2004-07       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.